Spots Global Cancer Trial Database for Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

Official Title: Novel Treatment to Enhance Smoking Cessation Before Cancer Surgery

Study ID: NCT02402023

Conditions

Smoking Cessation

Interventions

Contingency Management (CM)

Standard of Care (SC)

Study Description

Brief Summary: The purpose of this clinical trial is to determine the feasibility and efficacy of an intervention designed to increase rates of tobacco abstinence for cancer patients before their cancer surgery.

Detailed Description: The investigators are proposing a developmental interdisciplinary pilot study to determine the feasibility and efficacy of an intervention designed to increase rates of tobacco abstinence for cancer patients before their cancer surgery. This study (a follow up to smaller pilot studies) will serve as a means to further develop a treatment protocol and to generate an accurate effect size for a full scale trial. The present study will constitute a development clinical trial with a primary aim of developing an effect size for smoking cessation at the time of surgery (7-day point prevalence abstinence), and a secondary aim of creating an effect size for long-term abstinence at 3 months post-surgery.